Dr. Hatou presented Cellusion business progress in the 2022 Cell & Gene Meeting on the Mesa

Carlsbad, CA, USA (October 11-13, 2022)-, Dr. Hatou, founder & CEO of Cellusion Inc., presents recent business progress in the 2022 Cell & Gene Meeting on the Mesa. The Cell & Gene Meeting on the Mesa is well known an international conference organized by the Alliance for Regenerative Medicine, where more than 100 pharmaceutical, startup, and academic organizations working on the social implementation of regenerative medicine gather to discuss on various issues. Cellusion is happy to join this international community of regenerative medicine and accelerate our research program to deliver novel therapies for bullous keratopathy patients all over the world.

[About the Cell & Gene Meeting on the Mesa]
https://meetingonthemesa.com/

For further information: please ask us through contact form in our website.

[About Cellusion Inc.]
Cellusion Inc. is a regenerative medicine startup from Keio University. The mission of Cellusion is to deliver novel therapies for all bullous keratopathy patients by our iPS cells origin corneal endothelial cells mass culture system.
Company ： Cellusion Inc.
CEO ： Shin Hatou, M.D., Ph.D.
Headquarter ：8-6 Nihonbashi-Kobunacho, Chuo, Tokyo 103-0024, JAPAN
Founded ： January 2015
URL ： https://cellusion.jp/en/